These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
430 related items for PubMed ID: 19527689
21. Cloning, expression and investigation for polymorphisms of canine peroxisome proliferator-activated receptors. Nishii N, Takasu M, Soe OK, Maeda S, Ohba Y, Inoue-Murayama M, Kitagawa H. Comp Biochem Physiol B Biochem Mol Biol; 2007 Aug; 147(4):690-7. PubMed ID: 17512769 [Abstract] [Full Text] [Related]
22. In vitro screening of 200 pesticides for agonistic activity via mouse peroxisome proliferator-activated receptor (PPAR)alpha and PPARgamma and quantitative analysis of in vivo induction pathway. Takeuchi S, Matsuda T, Kobayashi S, Takahashi T, Kojima H. Toxicol Appl Pharmacol; 2006 Dec 15; 217(3):235-44. PubMed ID: 17084873 [Abstract] [Full Text] [Related]
24. Role of PPARalpha in mediating the effects of phthalates and metabolites in the liver. Lapinskas PJ, Brown S, Leesnitzer LM, Blanchard S, Swanson C, Cattley RC, Corton JC. Toxicology; 2005 Feb 01; 207(1):149-63. PubMed ID: 15590130 [Abstract] [Full Text] [Related]
25. Ligand-mediated regulation of peroxisome proliferator-activated receptor (PPAR) beta/delta: a comparative analysis of PPAR-selective agonists and all-trans retinoic acid. Rieck M, Meissner W, Ries S, Müller-Brüsselbach S, Müller R. Mol Pharmacol; 2008 Nov 01; 74(5):1269-77. PubMed ID: 18701617 [Abstract] [Full Text] [Related]
26. Peroxisome proliferator-activated receptor beta/delta exerts a strong protection from ischemic acute renal failure. Letavernier E, Perez J, Joye E, Bellocq A, Fouqueray B, Haymann JP, Heudes D, Wahli W, Desvergne B, Baud L. J Am Soc Nephrol; 2005 Aug 01; 16(8):2395-402. PubMed ID: 15944338 [Abstract] [Full Text] [Related]
27. The transcriptional PPARβ/δ network in human macrophages defines a unique agonist-induced activation state. Adhikary T, Wortmann A, Schumann T, Finkernagel F, Lieber S, Roth K, Toth PM, Diederich WE, Nist A, Stiewe T, Kleinesudeik L, Reinartz S, Müller-Brüsselbach S, Müller R. Nucleic Acids Res; 2015 May 26; 43(10):5033-51. PubMed ID: 25934804 [Abstract] [Full Text] [Related]
28. Δ9-Tetrahydrocannabinol upregulates fatty acid 2-hydroxylase (FA2H) via PPARα induction: A possible evidence for the cancellation of PPARβ/δ-mediated inhibition of PPARα in MDA-MB-231 cells. Hirao-Suzuki M, Takeda S, Watanabe K, Takiguchi M, Aramaki H. Arch Biochem Biophys; 2019 Feb 15; 662():219-225. PubMed ID: 30553767 [Abstract] [Full Text] [Related]
29. Inactivation of peroxisome proliferator-activated receptor isoforms alpha, beta/delta, and gamma mediate distinct facets of hypertrophic transformation of adult cardiac myocytes. Pellieux C, Montessuit C, Papageorgiou I, Lerch R. Pflugers Arch; 2007 Dec 15; 455(3):443-54. PubMed ID: 17643263 [Abstract] [Full Text] [Related]
30. Activation of mouse and human peroxisome proliferator-activated receptors (PPARs) by phthalate monoesters. Bility MT, Thompson JT, McKee RH, David RM, Butala JH, Vanden Heuvel JP, Peters JM. Toxicol Sci; 2004 Nov 15; 82(1):170-82. PubMed ID: 15310864 [Abstract] [Full Text] [Related]
31. Low-intensity exercise enhances expression of markers of alternative activation in circulating leukocytes: roles of PPARγ and Th2 cytokines. Yakeu G, Butcher L, Isa S, Webb R, Roberts AW, Thomas AW, Backx K, James PE, Morris K. Atherosclerosis; 2010 Oct 15; 212(2):668-73. PubMed ID: 20723894 [Abstract] [Full Text] [Related]
32. Peroxisome proliferator-activated receptors and inflammation. Moraes LA, Piqueras L, Bishop-Bailey D. Pharmacol Ther; 2006 Jun 15; 110(3):371-85. PubMed ID: 16168490 [Abstract] [Full Text] [Related]
33. Activation of mouse and human peroxisome proliferator-activated receptors (alpha, beta/delta, gamma) by perfluorooctanoic acid and perfluorooctane sulfonate. Takacs ML, Abbott BD. Toxicol Sci; 2007 Jan 15; 95(1):108-17. PubMed ID: 17047030 [Abstract] [Full Text] [Related]
34. PPARbeta/delta activation inhibits angiotensin II-induced collagen type I expression in rat cardiac fibroblasts. Zhang H, Pi R, Li R, Wang P, Tang F, Zhou S, Gao J, Jiang J, Chen S, Liu P. Arch Biochem Biophys; 2007 Apr 01; 460(1):25-32. PubMed ID: 17346664 [Abstract] [Full Text] [Related]
35. Regulation of inflammation by PPARs: a future approach to treat lung inflammatory diseases? Becker J, Delayre-Orthez C, Frossard N, Pons F. Fundam Clin Pharmacol; 2006 Oct 01; 20(5):429-47. PubMed ID: 16968414 [Abstract] [Full Text] [Related]
36. Growth of transgenic RAF-induced lung adenomas is increased in mice with a disrupted PPARbeta/delta gene. Müller-Brüsselbach S, Ebrahimsade S, Jäkel J, Eckhardt J, Rapp UR, Peters JM, Moll R, Müller R. Int J Oncol; 2007 Sep 01; 31(3):607-11. PubMed ID: 17671688 [Abstract] [Full Text] [Related]
37. Peroxisome proliferator-activated receptors in squamous cell carcinoma and its precursors. Nijsten T, Geluyckens E, Colpaert C, Lambert J. J Cutan Pathol; 2005 May 01; 32(5):340-7. PubMed ID: 15811118 [Abstract] [Full Text] [Related]
38. PPARbeta/delta agonists modulate platelet function via a mechanism involving PPAR receptors and specific association/repression of PKCalpha--brief report. Ali FY, Hall MG, Desvergne B, Warner TD, Mitchell JA. Arterioscler Thromb Vasc Biol; 2009 Nov 01; 29(11):1871-3. PubMed ID: 19696401 [Abstract] [Full Text] [Related]
39. PPARgamma-dependent regulation of human macrophages in phagocytosis of apoptotic cells. Majai G, Sarang Z, Csomós K, Zahuczky G, Fésüs L. Eur J Immunol; 2007 May 01; 37(5):1343-54. PubMed ID: 17407194 [Abstract] [Full Text] [Related]
40. Cloning of peroxisome proliferators activated receptors in the cobia (Rachycentron canadum) and their expression at different life-cycle stages under cage aquaculture. Tsai ML, Chen HY, Tseng MC, Chang RC. Gene; 2008 Dec 01; 425(1-2):69-78. PubMed ID: 18762234 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]